-
Company Profile
Ameriprise Financial Inc – Company Profile
Ameriprise Financial Inc (AFI) is a diversified financial service holding company, that offers wealth and asset management; cash, cards and lending solutions; insurance and annuities products; financial planning; and personal trust services, through its subsidiaries. Its wealth and asset management services consist of investment solutions such as individual retirement accounts, stock, and exchange-traded products, education savings, mutual funds, syndicate offerings, and real estate and alternative investments. The company offers cash management, accounts, cards, margin lending, and brokerage sweeps. AFI offers...
Add to Basket -
Product Insights
AFI Europe – AFIHOME Kolbenova Residential Community – Praha
Equip yourself with the essential tools needed to make informed and profitable decisions with our AFI Europe - AFIHOME Kolbenova Residential Community - Praha report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
AFI Mgmt – AFI City Mixed-Use Complex – Bucuresti
Equip yourself with the essential tools needed to make informed and profitable decisions with our AFI Mgmt - AFI City Mixed-Use Complex - Bucuresti report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AFI-002
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AFI-002 Drug Details AFI-002 is under development for the treatment of attention deficit hyperactivity...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AFI-003
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AFI-003 Drug Details AFI-003 is under development for the treatment of severe pain. The...
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity, and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination, and inability to sustain attention on tasks or activities. Treatment includes analeptics. The ADHD Drugs in Development market research report provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for ADHD, complete with analysis by stage of development, drug target, mechanism of...